Please enable JS

Healthcare

Title Published Pages Region Price
OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024 Dec 1 2015 326 Global $9,495.00
Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation Dec 1 2015 65 Global $6,995.00
Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape Dec 1 2015 138 Global $4,995.00
Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth Dec 1 2015 133 Global $4,995.00
COPD Therapeutics in Major Developed Markets to 2021 - Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading Brands Nov 13 2015 122 Global $4,995.00
MediPoint: Endoscopy - Global Analysis and Market Forecasts Nov 1 2015 347 Global $6,495.00
PharmaPoint: Multiple Myeloma - Global Drug Forecast and Market Analysis to 2023 Nov 1 2015 262 Global $10,995.00
Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations Nov 1 2015 159 Global $4,995.00
Prostate Cancer Market to 2021 - Increasing Disease Prevalence to be a Key Driver of Market Growth Nov 1 2015 164 Global $4,995.00
OpportunityAnalyzer: Clostridium difficile Infections (CDI) - Opportunity Analysis and Forecasts to 2024 Oct 9 2015 322 Global $9,495.00
PharmaPoint: Peripheral Artery Disease - Global Drug Forecast and Market Analysis to 2024 Oct 1 2015 404 Global $10,995.00
Multiple Myeloma Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments Oct 1 2015 117 Asia Pacific $4,995.00
Frontier Pharma: Obesity - Identifying and Commercializing First-in-Class Innovation Oct 1 2015 87 Global $6,995.00
Peripheral Artery Disease - US Drug Forecast and Market Analysis to 2024 Oct 1 2015 260 USA $4,995.00
Peripheral Artery Disease - Japan Drug Forecast and Market Analysis to 2024 Oct 1 2015 257 Japan $4,995.00
Peripheral Artery Disease - China Drug Forecast and Market Analysis to 2024 Oct 1 2015 258 China $4,995.00
Peripheral Artery Disease - 5EU China Drug Forecast and Market Analysis to 2024 Oct 1 2015 272 Europe $6,995.00
Peripheral Artery Disease - Current and Future Players Oct 1 2015 85 Global $2,995.00
Multiple Sclerosis - US Drug Forecast and Market Analysis to 2024 Sep 10 2015 233 USA $4,995.00
Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2024 Sep 10 2015 231 Canada $4,995.00
Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2024 Sep 10 2015 230 Japan $4,995.00
Multiple Sclerosis - China Drug Forecast and Market Analysis to 2024 Sep 10 2015 230 China $4,995.00
Multiple Sclerosis - 5EU Drug Forecast and Market Analysis to 2024 Sep 10 2015 246 Europe $6,995.00
Multiple Sclerosis - India Drug Forecast and Market Analysis to 2024 Sep 10 2015 228 India $4,995.00
Multiple Sclerosis - Current and Future Players Sep 10 2015 83 Global $2,995.00
Human Immunodeficiency Virus (HIV) - US Drug Forecast and Market Analysis to 2023 Sep 9 2015 302 USA $4,995.00
Human Immunodeficiency Virus (HIV) - Japan Drug Forecast and Market Analysis to 2023 Sep 9 2015 299 Japan $4,995.00
Human Immunodeficiency Virus (HIV) - 5EU Drug Forecast and Market Analysis to 2023 Sep 9 2015 305 Europe $6,995.00
Human Immunodeficiency Virus (HIV) - Brazil Drug Forecast and Market Analysis to 2023 Sep 9 2015 297 Brazil $4,995.00
Human Immunodeficiency Virus (HIV) - China Drug Forecast and Market Analysis to 2023 Sep 9 2015 298 China $4,995.00

Pages